JAAQ secures £13m to embed clinical mental-health content via AI video journeys
This article covers JAAQ, a healthtech startup, which has raised £13m in a growth funding round that marks its move into Series A stage to accelerate enterprise deployments, deepen clinical infrastructure and begin US expansion. The funding will support development of a clinically governed digital engagement platform to be embedded inside insurers', employers' and healthcare organisations' digital experiences, targeting scalable mental health engagement for enterprise customers.
JAAQ, a healthtech startup, has raised £13m in a growth funding round to accelerate enterprise deployments, deepen clinical infrastructure and begin US expansion; the company says the raise also marks its move into Series A-stage. The funding will support product development for a clinically governed digital engagement platform that embeds mental health content and AI-powered journeys inside insurers’, employers’ and healthcare organisations’ digital experiences.
Why it matters
Mental health demand continues to outstrip clinical capacity, and employers, insurers and health systems are looking for ways to reach people at scale without replacing one-to-one care. JAAQ’s proposition sits at that intersection: a clinically governed content layer designed to be embedded inside existing digital journeys, rather than a standalone consumer app.
For enterprise customers, the immediate value is engagement and measurable pathways that aim to shift behaviour across large populations. For the wider healthtech market, the deal signals continued investor appetite for clinically backed, enterprise-focused approaches rather than purely consumer-facing wellbeing apps.
Inside the product
At the platform’s core is a library of more than 10,000 clinically reviewed videos and lived-experience content, combined with AI tooling that stitches those assets into personalised journeys. Partners can either license content to integrate into their own products or opt for a bespoke JAAQ-hosted experience.
The company says it is building engineering and AI infrastructure to make this content an “intelligence layer” for digital products — enabling what it describes as clinically governed activation that can influence behaviour change at scale. Clinical governance and safety are positioned as central design constraints: without trust, JAAQ argues, enterprise deployment and impact are limited.
JAAQ is already deployed through active enterprise partnerships covering over 1.5 million eligible lives across insurers, employers and healthcare organisations. The new funding is earmarked for accelerating those deployments, investing in clinical validation and research, and launching US pilots.
In the announcement, Alex Packham, CEO, JAAQ, said:
We have a structural problem in mental health: demand is infinite, capacity is finite. The answer isn’t choosing between technology and therapists, it's using technology to reach millions of people who will never see a therapist. Clinically governed mental health content, embedded inside the digital experiences people already use, is how we close that gap. But this isn’t just a mental health story, it's a digital engagement story too. Organisations want their users to actually engage with what they build. JAAQ is the platform that makes both happen, safely and at scale.
In the announcement, Saurabh Johri, Chief Product & Technology Officer, JAAQ, said:
Having worked across healthcare for two decades, from research through to product, I’ve learned that what separates platforms that get adopted from those that don’t is trust: earned through clinical rigour, and through personalised experiences that reflect the individual not the population. Mental health is not one size that fits all, and the content and processes that govern what we deliver reflect that.
What excites me about JAAQ is the content proposition itself, we’re developing a new modality that combines conversational AI with video, to give people a simple, tailored way to understand their health. Not another chatbot. Something that meets people where they are, in a format that feels native to how they already consume information, underpinned by clinical credibility at every layer.
The infrastructure we’re building is designed to make that experience scalable, safe, and deeply integrated into the digital environments where people already are.
Who are the investors?
The round includes investment from Meridian Health Ventures, Fuel Ventures, Bolt Angels and Guinness Ventures. As part of the deal, Dr Pooja Sikka, Partner at Meridian Health Ventures, has joined JAAQ’s board.
Investors point to JAAQ’s institutional integrations and clinically governed model as the rationale for backing a product aimed at enterprise adoption rather than consumer downloads. In the announcement, Dr Pooja Sikka, Partner, Meridian Health Ventures, said:
JAAQ is solving a critical problem in mental health: not replacing care, but unlocking access to it. Their clinically governed approach and institutional integrations are exactly what the market needs. Their approach is unique. We believe JAAQ will become the infrastructure of mental health engagement for healthcare systems at a time when demand is overwhelming.
In the announcement, Shiv Patel, Partner, Fuel Ventures, said:
We’re delighted to be backing Alex again. What stood out to us is JAAQ’s ability to combine purpose with a commercially robust model. This is a platform designed for real-world adoption, scale and business impact, not just downloads.
If you're researching potential backers in this space:
- Explore our list of healthtech venture capital firms in the UK
- Browse our directory of healthtech angel investors in the UK
Founder perspective
Alex Packham has joined as CEO; the announcement notes he is a serial entrepreneur and technology investor whose prior business was acquired by Adobe. The leadership team also includes Saurabh Johri, PhD, as Chief Product & Technology Officer, who brings two decades of work at the intersection of AI, machine learning and healthcare product development.
The team frames JAAQ’s challenge as building trusted clinical infrastructure at engineering scale — combining content, governance and AI to make enterprise integration tractable for customers that require safety and measurable outcomes.
The bigger picture
This round illustrates a broader shift in UK healthtech towards enterprise-facing, clinically validated digital products that integrate with insurers and health systems. Investors are signalling preference for companies that can demonstrate uptake across institutional partners and that prioritise governance and validation as part of go-to-market.
For JAAQ, the immediate priorities — deeper clinical validation, scaling enterprise partnerships and US pilots — mirror common steps for UK healthtech startups seeking cross-border growth. The emphasis on embedding content into existing digital journeys also reflects a maturing view of digital mental health: interventions must fit into workflows and platforms people already use if they are to reach millions.
The funding comes at a time when demand for mental health support is growing across Europe and North America, and when payers and employers are increasingly looking for scalable, clinically supervised digital options that complement traditional care.
They've invested in JAAQ
Get to know these healthtech investors
Click here for a full list of 7,526+ startup investors in the UK